AKO Capital's position in Illumina is currently worth $51.3M. That's 0.75% of their equity portfolio (19th largest holding). AKO Capital started to build up the position in Illumina in Q4 2024 and continued to invest until Q1 2025. Since then they sold 356k shares. The investor's estimated purchase price is $68.1M, resulting in a loss of 25%.
On June 25, 2024, Illumina, Inc. (NASDAQ: ILMN, $208.92, Market Capitalization: $18.51 billion) announced the completion of the tax free spin-off of GRAIL, I...
On June 3, 2024, Illumina's (NASDAQ: ILMN, $109.82, Market Capitalization: $17.5 billion) board of directors approved the spin-off of its wholly owned subsid...
Illumina, Inc. (NASDAQ:NASDAQ:ILMN) RBC Capital Markets Global Healthcare Call May 14, 2024 8:30 AM ETCompany ParticipantsAnkur Dhingra - Chief Financial¡
Patient Capital Management, a value investing firm, released its ¡°Patient Capital Opportunity Equity Strategy¡± fourth quarter 2023 investor letter. A copy of...